A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model

BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a life-threatening disease in immunosuppressed patients. Voriconazole is commonly used to prevent and treat IPA in the clinic, but the optimal prophylactic antifungal regimen is unknown. The objective of this study was to clarify the mechanism un...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Taotao, Zhang, Tao, Meng, Ti, Li, Ying, Chen, Lu, Yang, Qianting, Dong, Haiyan, Lei, Jin’e, Chen, Limei, Dong, Yalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992762/
https://www.ncbi.nlm.nih.gov/pubmed/29880050
http://dx.doi.org/10.1186/s12967-018-1533-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992762/
https://www.ncbi.nlm.nih.gov/pubmed/29880050
http://dx.doi.org/10.1186/s12967-018-1533-4

Ejemplares similares